1208 related articles for article (PubMed ID: 31472168)
1. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
[TBL] [Abstract][Full Text] [Related]
2. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.
Sanchez-Freire V; Lee AS; Hu S; Abilez OJ; Liang P; Lan F; Huber BC; Ong SG; Hong WX; Huang M; Wu JC
J Am Coll Cardiol; 2014 Aug; 64(5):436-48. PubMed ID: 25082575
[TBL] [Abstract][Full Text] [Related]
3. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
4. Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells.
Nsair A; Schenke-Layland K; Van Handel B; Evseenko D; Kahn M; Zhao P; Mendelis J; Heydarkhan S; Awaji O; Vottler M; Geist S; Chyu J; Gago-Lopez N; Crooks GM; Plath K; Goldhaber J; Mikkola HK; MacLellan WR
PLoS One; 2012; 7(10):e45603. PubMed ID: 23056209
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts.
Wang L; Nguyen T; Rosa-Garrido M; Zhou Y; Cleveland DC; Zhang J
Front Bioeng Biotechnol; 2023; 11():1108340. PubMed ID: 36845191
[No Abstract] [Full Text] [Related]
6. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.
Yoshida S; Miyagawa S; Fukushima S; Kawamura T; Kashiyama N; Ohashi F; Toyofuku T; Toda K; Sawa Y
Mol Ther; 2018 Nov; 26(11):2681-2695. PubMed ID: 30217728
[TBL] [Abstract][Full Text] [Related]
7. Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
[TBL] [Abstract][Full Text] [Related]
9. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
10. Contribution of two-pore K
Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
[TBL] [Abstract][Full Text] [Related]
11. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Zhou J; Cui B; Wang X; Wang H; Zheng J; Guo F; Sun Y; Fan H; Shen J; Su J; Wang J; Zhao H; Tang Y; Gong T; Sun N; Liang P
Stem Cell Res Ther; 2023 Apr; 14(1):92. PubMed ID: 37061738
[TBL] [Abstract][Full Text] [Related]
14. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
17. Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Fong AH; Romero-López M; Heylman CM; Keating M; Tran D; Sobrino A; Tran AQ; Pham HH; Fimbres C; Gershon PD; Botvinick EL; George SC; Hughes CC
Tissue Eng Part A; 2016 Aug; 22(15-16):1016-25. PubMed ID: 27392582
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
[TBL] [Abstract][Full Text] [Related]
19. Comparative Gene Expression Analyses Reveal Distinct Molecular Signatures between Differentially Reprogrammed Cardiomyocytes.
Zhou Y; Wang L; Liu Z; Alimohamadi S; Yin C; Liu J; Qian L
Cell Rep; 2017 Sep; 20(13):3014-3024. PubMed ID: 28954220
[TBL] [Abstract][Full Text] [Related]
20. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
